# Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)

> **NCT01228318** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 63 (actual)

## Conditions studied

- HIV Infection
- Bone Loss
- Osteopenia
- Osteoporosis

## Interventions

- **DRUG:** Zoledronic acid

## Key facts

- **NCT ID:** NCT01228318
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2017-04-13
- **Final completion:** 2017-04-13
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2018-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01228318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01228318, "Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01228318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*